Search

for
Search:

GlossaryHydroxyurea (Hydroxycarbamide)

medication that inhibits DNA synthesis to treat cancer and blood disorders

Hydroxyurea, also known as hydroxycarbamide, is a medication primarily used to treat certain types of cancer, such as chronic myelogenous leukemia, and blood disorders like sickle cell anemia. It works by inhibiting DNA synthesis, which helps to slow the growth of cancer cells and reduce the frequency of painful sickle cell crises.

Related Terms

Sort by

Research

6 / 6 results

research Essential Thrombocythemia: The Dermatologic Point of View

22 citations, September 2015 in “Clinical lymphoma myeloma & leukemia/Clinical lymphoma, myeloma and leukemia”

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

research Treatment of Recurrent Priapism in Sickle Cell Anemia With Finasteride: A New Approach

57 citations, July 2009 in “Urology”

Finasteride helps reduce priapism in sickle cell anemia patients.

research Drug Eruptions

November 2014

Any medication can cause skin reactions, some due to allergies and others due to dosage or genetic factors.

research Anticancer Drugs in Surface Waters

310 citations, November 2011 in “Environment International”

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

research Cell Death by Cornification

375 citations, June 2013 in “Biochimica et biophysica acta. Molecular cell research”

Cornification is how skin cells die to form the protective outer layer of skin, hair, and nails.

research Key Factors in the Complex and Coordinated Network of Skin Keratinization: Their Significance and Involvement in Common Skin Conditions

2 citations, December 2023 in “International journal of molecular sciences”

Understanding keratinization is crucial for treating skin conditions like ichthyoses and psoriasis.